Alzheimer's Family Research
Proxy Decision Making for Alzheimer Disease Research
This is a research study about how family members make research participation decisions for a relative with Alzheimer's or a related dementia. The purpose of this study is to learn more about how proxies (the family member who makes decisions for that relative), would think through decisions about whether to enroll their relative in studies for not-yet-approved medications for Alzheimer's Disease. The long-term goal of the study is to improve the way researchers inform families about clinical research studies and opportunities for participation. This study is being sponsored by the National Institute on Aging.
Study participants will be interviewed by a research staff member about research enrollment decisions for their relative. A number of standardized questionnaires will be administered. There is only one visit required. The interview lasts about three hours. The investigators will try to make it as convenient as possible for your schedule.
This is a non-intervention study. UCSF CHR # H58055-31168-02 v.1 Date: 012709
研究概览
地位
条件
详细说明
- The researcher will interview you for about 3 hours in a private office.
- Study location: All these procedures will be done at Dr. Dunn's research offices at UCSF. If you prefer, we can conduct the interview at your home in or near the San Francisco bay area.
- You will be asked questions about your general background, and about how providing care for the person with Alzheimer's Disease has affected you. You will also be asked some basic questions about the person with Alzheimer's Disease (such as how well they are functioning; personal information will not be collected, however).
- Then, you will be given a consent form for an imaginary study related to Alzheimer Disease. An imaginary study means that it is not a real study, but it is a made-up one. You or your relative will not really participate in the study that is described in the consent form, because it is only imaginary and created just for this research.
- Then, you will be asked questions to measure how well you understood the information presented to you. For example, you will be asked about the procedures, risks and benefits.
- You will also be interviewed regarding your opinions and attitudes about research participation. If you give your permission, we will audiotape this interview to help us more accurately record this information. You may refuse to answer any of the questions that make you uncomfortable. You do not have to agree to be audio-taped to participate in this study.
- You will be given some tests designed to measure memory, attention and other thinking abilities. These tests are for research purposes only, and are not being used for any type of diagnostic purposes. The research purpose is to help us understand proxies' abilities to make decisions as caregivers for seriously ill patients.
- You will be asked questions about your mood and about caring for someone with dementia. You may refuse to answer and questions that make you uncomfortable.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
California
-
San Francisco、California、美国、94143
- UCSF Langley Porter Institute, or at participant's home
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- A family member-caregiver (the medical decision-maker) for someone with Alzheimer's Disease
- Able to be interviewed in person in or around the San Francisco Bay Area
- Able to read and understand English
Exclusion Criteria:
- People who do not meet inclusion criteria or who become uncooperative or unwilling to complete the interview
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
---|
Proxies
A family member-caregiver (the medical decision-maker) for someone with Alzheimer's Disease.
Must be the person who would be able to make decisions for someone with Alzheimer's disease about being in medical research.
|
合作者和调查者
调查人员
- 首席研究员:Laura B Dunn, MD、University of California, San Francisco
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- AD R01
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.